– Healey to be honored at the 14th Annual Fundraising Gala –
DAMASCUS, Md. – April 28, 2016 – The Sarcoma Foundation of America (SFA), an organization dedicated to increased research funding and advocacy for sarcoma, is pleased to announce that John H. Healey, MD, FACS, Chief of Orthopaedic Surgery at Memorial Sloan-Kettering Cancer Center, is the 2016 recipient of the Nobility in Science Award. Dr. Healey will be honored at SFA’s 14th Annual New York fundraising gala, “A Celebration of Life.” The event will take place on May 12, 2016, at Guastavino’s, 409 E 59th Street, New York, NY.
The Nobility in Science Award is given to an outstanding scientist who is dedicated to the advancement of knowledge of sarcoma and works tirelessly to find new and innovative approaches for treating the rare cancer. Dr. Healey is being honored for his distinguished career as a surgeon and for his dedication to finding a cure for sarcoma.
“Dr. Healey is known worldwide as an expert in orthopedic surgical oncology,” said SFA Chief Executive Officer Bert E. Thomas IV, PhD, MBA. “Everywhere I travel, I find patients who have been touched by the care they received from Dr. Healey. He has saved so many lives through his skill as a surgeon and his understanding of sarcoma. His impact through his research cuts across all aspects of sarcoma. We are proud to honor Dr. Healey for everything he has done to make this a better world for all sarcoma patients and survivors.”
“A Celebration of Life” honors those who have battled sarcoma, as well as those who have dedicated their lives and careers to the treatment of sarcoma patients. The event raises money to fund innovative sarcoma research that will lead to the development of new and better therapies for sarcoma patients. Further information about the Sarcoma Foundation of America and the 2016 NYC Fundraiser, “A Celebration of Life,” can be found at https://www.curesarcoma.org/nyccelebration/.
About the Sarcoma Foundation of America
The Sarcoma Foundation of America (SFA), a 501(c)(3) nonprofit charitable organization, is an advocate for increased research to find new and better therapies with which to treat patients with sarcoma. The organization raises money to privately fund grants for sarcoma researchers and conducts education and advocacy efforts on behalf of sarcoma patients. For more information, please visit www.curesarcoma.org.
Sarcoma is a rare cancer in adults (1 percent of all adult cancers) but rather prevalent in children (about 15 percent of all childhood cancers). At any one time, 50,000 patients and their families are struggling with sarcoma. Every year, nearly 15,000 new cases are diagnosed and about 6,000 people die from the disease.
Contact: Lori Hoffman